The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIDA R25 program is to support educational activities that enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.
This FOA solicits applications to develop and implement research education programs/short courses in entrepreneurship, innovation and product development specifically targeting bench life scientists. The institution proposing the course must be a research-intensive institution that has an established and well-recognized entrepreneurship teaching program with the demonstrated ability and willingness to adapt/develop and deliver the integrated curriculum for the academic life scientists, including scientists working in the field of drug abuse and addiction research. The short courses should primarily target independent academic neuroscience researchers and post-doctoral fellows interested in incorporating product (drug, device, diagnostics, research tool, mobile health application, etc.) development into their research programs with the goal of future commercialization.
Deadlines:
RFA-DA-17-007 Expiration Date July 21, 2016
The PD/PI should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI will be expected to monitor and assess the program and submit all documents and reports as required.
Researchers from diverse backgrounds, including racial and ethnic minorities, persons with disabilities, and women are encouraged to participate as preceptors/mentors. Enterpreneurship courses should include faculty with extensive experience in biomedical product development and commercialization. Faculty should be drawn from both academia and industry and include a diverse range of perspectives. Faculty may also include representatives from government agencies, such the Food and Drug Administration (FDA) and Centers for Medicare and Medicaid Services (CMS).
